RU2296121C2 - Соединения, способ их получения, способы лечения - Google Patents

Соединения, способ их получения, способы лечения Download PDF

Info

Publication number
RU2296121C2
RU2296121C2 RU2004112217/04A RU2004112217A RU2296121C2 RU 2296121 C2 RU2296121 C2 RU 2296121C2 RU 2004112217/04 A RU2004112217/04 A RU 2004112217/04A RU 2004112217 A RU2004112217 A RU 2004112217A RU 2296121 C2 RU2296121 C2 RU 2296121C2
Authority
RU
Russia
Prior art keywords
formula
compound
group
deoxy
hydroxy
Prior art date
Application number
RU2004112217/04A
Other languages
English (en)
Russian (ru)
Other versions
RU2004112217A (ru
Inventor
Милан Радое УСКОКОВИЦ (US)
Милан Радое УСКОКОВИЦ
Original Assignee
Ф.Хоффманн-Ля Рош Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ф.Хоффманн-Ля Рош Аг filed Critical Ф.Хоффманн-Ля Рош Аг
Publication of RU2004112217A publication Critical patent/RU2004112217A/ru
Application granted granted Critical
Publication of RU2296121C2 publication Critical patent/RU2296121C2/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/18Drugs for disorders of the endocrine system of the parathyroid hormones
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
RU2004112217/04A 2001-09-21 2002-09-12 Соединения, способ их получения, способы лечения RU2296121C2 (ru)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US32387001P 2001-09-21 2001-09-21
US32395701P 2001-09-21 2001-09-21
US60/323957 2001-09-21
US60/323,957 2001-09-21
US60/323,870 2001-09-21
US60/323870 2001-09-21

Publications (2)

Publication Number Publication Date
RU2004112217A RU2004112217A (ru) 2005-07-10
RU2296121C2 true RU2296121C2 (ru) 2007-03-27

Family

ID=26984180

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2004112217/04A RU2296121C2 (ru) 2001-09-21 2002-09-12 Соединения, способ их получения, способы лечения

Country Status (14)

Country Link
EP (1) EP1430026A1 (xx)
JP (1) JP2005503434A (xx)
KR (1) KR100628586B1 (xx)
CN (1) CN1285573C (xx)
AU (1) AU2002338672B2 (xx)
BR (1) BR0212719A (xx)
CA (1) CA2459789A1 (xx)
MX (1) MXPA04002640A (xx)
PA (1) PA8554901A1 (xx)
PE (1) PE20030429A1 (xx)
PL (1) PL370352A1 (xx)
RU (1) RU2296121C2 (xx)
UY (1) UY27448A1 (xx)
WO (1) WO2003027065A1 (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050055784A (ko) * 2002-10-23 2005-06-13 레오 파마 에이/에스 비타민 디 유사체, 이 유사체를 포함하는 조성물 및 이들의용도
JP2008514621A (ja) * 2004-09-24 2008-05-08 ビオクセル エッセ ピ ア 20−シクロアルキル,26,27−アルキル/ハロアルキル−ビタミンd3化合物及びその使用方法
AU2005303773A1 (en) 2004-11-12 2006-05-18 Bioxell Spa Combined use of vitamin D derivatives and anti-proliferative agents for treating bladder cancer
CN102124301B (zh) 2008-08-22 2014-04-02 Nxp股份有限公司 基于位置的服务
CN110339205B (zh) * 2019-08-19 2021-08-24 山东德信生物科技有限公司 富氢水组合物在抑制六价铬诱导的df-1细胞内质网应激及自噬中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG70010A1 (en) * 1996-05-23 2000-01-25 Hoffmann La Roche Fluorinated vitamin d3 analogs
JP4219553B2 (ja) * 1997-09-08 2009-02-04 エフ.ホフマン−ラ ロシュ アーゲー 1,3−ジヒドロキシ−20,20−ジアルキル−ビタミンd3類似体
US6331642B1 (en) * 1999-07-12 2001-12-18 Hoffmann-La Roche Inc. Vitamin D3 analogs

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KOIKE, MICHIAKI et al. Anticancer Research. V.l9, №3А, 1999, p.1689-1697. *

Also Published As

Publication number Publication date
AU2002338672B2 (en) 2006-03-09
WO2003027065A1 (en) 2003-04-03
BR0212719A (pt) 2004-08-03
CA2459789A1 (en) 2003-04-03
KR20040035853A (ko) 2004-04-29
PA8554901A1 (es) 2003-12-10
CN1285573C (zh) 2006-11-22
JP2005503434A (ja) 2005-02-03
CN1556795A (zh) 2004-12-22
EP1430026A1 (en) 2004-06-23
PE20030429A1 (es) 2003-05-15
UY27448A1 (es) 2003-03-31
PL370352A1 (en) 2005-05-16
MXPA04002640A (es) 2004-06-07
RU2004112217A (ru) 2005-07-10
KR100628586B1 (ko) 2006-09-26

Similar Documents

Publication Publication Date Title
ES2309069T3 (es) Compuestos de 2-etil y 2-etiliden-19-nor-vitamina d.
AU707942B2 (en) New vitamin D derivatives with substituents at C-25, process for their production, intermediate products and use for the production of pharmaceutical agents
US5872113A (en) Fluorinated vitamin D3 analogs
JP4988551B2 (ja) 2−アルキリデン18,19−ジノル−ビタミンd化合物
EP1015423B1 (en) 1,3-dihydroxy-20,20-dialkyl-vitamin d 3? analogs
JPH02288854A (ja) 1α,25―ジヒドロキシル化ビタミンD↓2
CA2480125C (en) Use of carbon-2-modified-19-nor-vitamin d analogs to induce the formation of new bone
HRP980224A2 (en) Vitamin d3 analogs with bis c-20 side chains
AU2004273660B2 (en) Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and parathyroid hormone
RU2296121C2 (ru) Соединения, способ их получения, способы лечения
KR100351490B1 (ko) 비스 씨-20 측쇄를 갖는 비타민 디3 유사체
CA2205315C (en) Fluorinated vitamin d3 analogs
US6559138B1 (en) 3-Desoxy-vitamin D3 analog esters
WO2006042383A1 (en) Vitamin-d analogue useful in a pharmaceutical composition
AU2002338672A1 (en) 3-desoxy-vitamin D3 analog esters
RU2223953C2 (ru) Аналоги витамина D, фармацевтическая композиция, соединения
US7491711B2 (en) Methods of treatment using 3-desoxy vitamin D3 analogs
US5696103A (en) Method for treating osteoporosis
Manchand et al. Vitamin D3 analogs with BIS C-20 side chains
Manchand et al. Method of using Vitamin D3 analogs with BIS C-20 side chains

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20080913